Review Article
Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines
Table 2
Status of development of whole yeast-based vaccines.
| | Pathogen | Antigen | Yeast host | Expression system | Indication | Clinical trial status | Clinical trial ID | Refs |
| | HBV | HBV (X/S/core) | Saccharomyces cerevisiae | Stable | Chronic HBV | Phase 2 | NCT01943799 | [73] | | NCT02174276 | | HCV | HCV (NS3/core) | Saccharomyces cerevisiae | Stable | Chronic HCV | Phase 2 | NCT00606086 | [74] |
|
|
X: hepatitis B regulatory protein; S: hepatitis B surface antigen; NS3: hepatitis C nonstructural protein.
|
